title: Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study.
abstract: Small, dense LDL has been shown to be associated with the insulin resistance syndrome and coronary heart disease (CHD). We examined the distribution of LDL size and phenotype within a population-based sample of American Indians to determine the relationships with prevalent CHD and to examine associations with hyperinsulinemia and other components of the insulin resistance syndrome. Data were available for 4505 men and women between 45 and 74 years of age who are members of 13 American Indian communities in three geographic areas. Diabetes, CHD, and CHD risk factors were assessed by standardized techniques, and LDL size was measured by gradient gel electrophoresis. LDL size was smaller in men than in women and in individuals with diabetes than in those without diabetes. In multivariate analysis, LDL size was significantly related to several components of the insulin resistance syndrome, including triglycerides (inversely) and HDL cholesterol (positively). Although univariate relations were positive, LDL size was not significantly related to fasting insulin concentrations or body mass index in the multivariate model. LDL size also showed no relationship to apolipoprotein E phenotype. When LDL size was compared in individuals with and without CHD, no significant differences were observed, either in nondiabetic or diabetic individuals. We conclude that LDL size is most strongly related to lipoprotein components of the insulin resistance syndrome, especially plasma triglycerides. However, in this population with low LDL, it is not related to cardiovascular disease.
authors.affiliation: Medlantic Research Institute, Washington, DC 20010-2933, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Gray
authors.forename: D C
authors.initials: DC
authors.lastname: Robbins
authors.forename: W
authors.initials: W
authors.lastname: Wang
authors.forename: J L
authors.initials: JL
authors.lastname: Yeh
authors.forename: R R
authors.initials: RR
authors.lastname: Fabsitz
authors.forename: L D
authors.initials: LD
authors.lastname: Cowan
authors.forename: T K
authors.initials: TK
authors.lastname: Welty
authors.forename: E T
authors.initials: ET
authors.lastname: Lee
authors.forename: R M
authors.initials: RM
authors.lastname: Krauss
authors.forename: B V
authors.initials: BV
authors.lastname: Howard
mesh_terms: D000368:Aged; D001794:Blood Pressure; D001798:Blood Proteins / Q000032:analysis; D001824:Body Constitution; D015992:Body Mass Index; D008076:Cholesterol, HDL / Q000097:blood; D015331:Cohort Studies; D003327:Coronary Disease / Q000453:epidemiology / Q000208:ethnology* / Q000235:genetics; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D007198:Indians, North American / Q000235:genetics*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics*; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000737:chemistry*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010316:Particle Size; D010641:Phenotype; D015995:Prevalence; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D013577:Syndrome; D014280:Triglycerides / Q000097:blood
chemical_list: D001798:Blood Proteins; D008076:Cholesterol, HDL; D007328:Insulin; D008055:Lipids; D008077:Lipoproteins, LDL; D014280:Triglycerides